Quanterix Corporation (QTRX)

15.51 -0.46 (-2.88%) 收市：04:00PM EDT

Quanterix Corporation

Building 1
900 Middlesex Turnpike
Billerica, MA 01821
United States
617 301 9400
https://www.quanterix.com

版塊: Healthcare
行業: Medical Devices
全職員工: 441

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Masoud Toloue Ph.D.	President, CEO & Director	1.44M	無	1981
Dr. David R. Walt Ph.D.	Co-Founder, Chairman of Scientific Advisory Board & Independent Director	47.25k	無	1953
Ms. Vandana Sriram CPA	CFO & Treasurer	552.16k	無	1974
Dr. Michael Miller Ph.D.	Chief Operating Officer	無	無	無
Ms. Alexandra Phillips	Senior VP & Chief Information Officer	無	無	無
Ms. Laurie A. Churchill	Senior VP, General Counsel & Secretary	無	無	1971
Mr. Naren Bhat	Senior Vice President of Corporate Development & Strategy	無	無	無
Ms. Erica Bell	Chief People Officer	無	無	1973
Dr. Mark T. Roskey Ph.D.	Chief Science & Collaboration Officer	495.03k	845.13k	1960
Mr. Darrin Crisitello M.B.A.	Senior VP & Chief Commercial Officer	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

公司管治

截至 2024年6月1日 止，Quanterix Corporation 的 ISS 管治質素評分為 9。 Pillar 分數正在審核中：8；董事會：10；股東權利：8；現金賠償：7。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。